SELL and COVID-19: We found that severe COVID-19 patients had greater frequencies of CD4+ T cells expressing CD62L compared to non-severe COVID-19 patients (p=0.01), and recovered patients had greater frequencies of these cells compared to non-severe patients (p=0.02) and healthy controls (p=0.04) (Figure 1A).